NUTXNutex Health Inc.

$195.69

The financials

Nutex Health Inc. by the numbers

Nutex Health Inc. (NUTX) reported revenue of $216M in Q1 2026 (quarter ended March 31, 2026), up 2.2% from the same quarter a year earlier. That came with a gross margin of 42% and net income of $47M (22% of revenue). For the full year FY2025, revenue was $875M (+82% year on year) and net income $71M. Its largest product in 2026-Q1 was Hospital Division at $208M, 96% of the disclosed total, just ahead of Population Health Management Division at 4.1%.

Nutex Health Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$216M$212M+2.2%
Gross profit$92M$118M−22%
Operating income$81M$81M+0.7%
Net income$47M$21M+121%
Diluted EPS$6.52$3.33+96%
Revenue by product, 2026-Q1, as reported to the SEC
ProductRevenueShare
Hospital Division$208M96%
Population Health Management Division$8.9M4.1%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q1 2026Total $216.5M (-19%)
Population Health Management Division grew +14% year on yearHospital Division +1.8% year on year
  • Hospital Division$207.6MQoQ -20%year on year +1.8%
  • Population Health Management Division$8.9MQoQ +18%year on year +14%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-04-30, SEC EDGAR